• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Average number of business days for CVM to complete the review of warning letters from ORA districts

Dictionary: CVM’s warning letter review ensures that the issued warning letter clearly follows the Agency’s rules, regulations and policies for the animal food/drug/device/biologics regulated industry and that these rules, regulations and policies are being implemented equally across all of the ORA district’s and internationally. Warning Letters are the Agency’s principal means of notifying the regulated industry of violations and achieving prompt voluntary correction. Warning letters need be issued soon after an inspection so the regulated industry is notified of their non-compliance. The regulated industry can then quickly implement corrective actions in order to become compliant with FDA’s rules, regulations and policies.

Information is current as of September 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

Oct 2013N/A17
Nov 2013N/A18
Dec 2013N/A26
Jan 2014N/A19
Feb 2014N/A6
Mar 2014N/A14
Apr 2014N/A7
May 2014N/A3
Jun 2014N/A8
Jul 2014N/A4
Aug 2014N/A34
Sep 2014N/A10

FY 2014 YTD: 14

Number of OSC full time employees reviewing warning letters at the end of the month

Fiscal Year - 2014

Skip graphic and jump to text data

Oct 2013N/A4
Nov 2013N/A4
Dec 2013N/A4
Jan 2014N/A4
Feb 2014N/A4
Mar 2014N/A4
Apr 2014N/A4
May 2014N/A4
Jun 2014N/A4
Jul 2014N/A4
Aug 2014N/A4
Sep 2014N/A4

FY 2014 YTD: 4


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.